The Department of Health and Social Care (DHSC) has today announced that it will impose a Flat Fee cut on pharmacy owners for March 2024. The Flat Fee – which has been paid to pharmacies dispensing more than 101 items per month since April 2023 following the end of transitional payment arrangements under the five-year
Read moreFollowing discussions between Community Pharmacy England and the Department of Health and Social Care (DHSC) regarding medicine pricing issues reported by pharmacy owners, the Department has today (29/02/2024) announced the following final list of price concessions for February 2024. Drug Pack size Price concession Aripiprazole 10mg tablets 28 £9.53 Aripiprazole 15mg tablets 28 £9.69 Aripiprazole
Read moreDepartment of Health and Social Care (DHSC) has issued a medicine supply notification for Midazolam (Epistatus®) 5mg/0.5ml oromucosal solution pre-filled oral syringes. MSN/2024/025 Tier 2 – medium impact Date of issue: 27th February 2024 Midazolam (Epistatus®) 5mg/0.5ml oromucosal solution pre-filled oral syringes are currently out of stock. Resupply date of this product is to be
Read moreThe Drug Tariff Preface published monthly lists additions, deletions and other changes to products listed in the Drug Tariff. Below is a summary of the changes coming into effect from 1 March 2024. Contractors should note changes made to Part II – Requirements enabling payments to be made for the supply of drugs, appliances and chemical
Read moreNational Patient Safety Alert: Shortage of salbutamol 2.5mg/2.5ml and 5mg/2.5ml nebuliser liquid unit dose vials National Patient Safety Alert Reference Number: NatPSA/2024/003/DHSC_MVA Date issued: 26 February 2024 Explanation of identified safety issue A Medicines Supply Notification (MSN) issued on 14 February 2024, detailed a shortage of salbutamol 2.5mg/2.5ml and 5mg/2.5ml nebuliser liquid. The resolution date
Read moreClass 4 Medicines Defect Information: Concerta® XL 18mg & 36 mg prolonged release tablets (Orifarm UK Ltd) Drug alert number: EL (24)A/07 Date issued: 26 February 2024 The Medicines and Health products Regulatory Agency (MHRA) has issued a class 4 medicines defect information notice for: Concerta® XL 18mg & 36 mg prolonged release tablets (Orifarm
Read moreFormal tripartite negotiations on the arrangements for the Community Pharmacy Contractual Framework (CPCF) in 2024/25 – the first year following the five-year CPCF deal – have now begun. The negotiations are taking place between Community Pharmacy England and the Department of Health and Social Care (DHSC), supported by NHS England (NHSE). They are beginning ahead
Read moreFollowing discussions between Community Pharmacy England and the Department of Health and Social Care (DHSC) regarding medicine pricing issues reported by pharmacy owners, the Department has today (23/02/2024) announced the following list of price concessions for February 2024. Please note: We are still in discussion with DHSC on a number other medicines affected by pricing
Read moreEli Lilly and Company Ltd has recently launched Mounjaro® (tirzepatide), a new diabetes drug which is also indicated for the treatment of weight loss. Mounjaro® comes in a KwikPen® or auto-injector pre-filled injection pen containing 2.5mg, 5mg, 7.5mg, 10mg, 12.5mg and 15mg of tirzepatide. Currently, only the 2.5mg and 5mg strengths of the KwikPen® are
Read moreDepartment of Health and Social Care (DHSC) has issued a medicine supply notification for Epilim® (sodium valproate) syrup 200mg/5ml MSN/2024/023 Tier 2 – medium impact Date of issue: 21st February 2024 Epilim® 200mg/5ml syrup is out of stock from mid-March until w/c 22nd April 2024. Epilim® (sodium valproate) 200mg/5ml liquid (sugar-free) remains available and can
Read more
